Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Other Working Capital Changes (2019 - 2025)

Historic Other Working Capital Changes for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to -$189000.0.

  • AVITA Medical's Other Working Capital Changes rose 9148.65% to -$189000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.3 million, marking a year-over-year increase of 368.76%. This contributed to the annual value of -$905000.0 for FY2025, which is 11.04% up from last year.
  • Per AVITA Medical's latest filing, its Other Working Capital Changes stood at -$189000.0 for Q4 2025, which was up 9148.65% from $136729.0 recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's Other Working Capital Changes ranged from a high of $1.9 million in Q1 2024 and a low of -$2.8 million during Q4 2023
  • Moreover, its 5-year median value for Other Working Capital Changes was $102312.0 (2025), whereas its average is -$76578.5.
  • Over the last 5 years, AVITA Medical's Other Working Capital Changes had its largest YoY gain of 774400.0% in 2023, and its largest YoY loss of 1399010.99% in 2023.
  • Quarter analysis of 5 years shows AVITA Medical's Other Working Capital Changes stood at $4400.0 in 2021, then tumbled by 4395.45% to -$189000.0 in 2022, then crashed by 1365.61% to -$2.8 million in 2023, then rose by 19.86% to -$2.2 million in 2024, then surged by 91.49% to -$189000.0 in 2025.
  • Its Other Working Capital Changes was -$189000.0 in Q4 2025, compared to $136729.0 in Q3 2025 and $123395.0 in Q2 2025.